2010 Research in Action Awards Honor Dr. Oz 12/12

Treatment Action Group (TAG), one of the leading AIDS research advocacy organizations, will host its 14th annual Research in Action Awards (RIAA), honoring individuals who have made a significant contribution in AIDS research and activism. Honorary Chairs will be playwright Terrence McNally and his husband, attorney/activist Tom Kirdahy. Sally Morrison, Director-in-Charge at De Beers Marketing Group, is RIAA Chair.

The 2010 Research in Action Awards will take place at the Gallery of the historic Astor Center (399 Lafayette Street) on Sunday, December 12 (6 PM). Jenna Wolfe of NBC's "Weekend Today" will serve as host.

TAG is proud to present its 2010 RIAA Awards to: Scott P. Campbell, Executive Director of the Elton John AIDS Foundation, who will be presented with his award by sports legend Billie Jean King; eminent researcher Dr. Steven Deeks, Professor of Medicine at University of California, San Francisco, who will receive his award from TAG's Executive Director Mark Harrington; best-selling author and host of "The Dr. Oz Show," Dr. Mehmet Oz, presented by John J. Mack, Chairman of New York-Presbyterian Hospital; and videographer/activist James Wentzy, who will receive his award from filmmaker Jean Carlomusto.

Founded in 1992, Treatment Action Group fights to ensure that all people living with HIV receive the necessary treatment, care, and information they need. Today, 25 years into this global pandemic, TAG remains the only organization in the world dedicated to AIDS research advocacy for better treatments, a vaccine, and cure for AIDS. TAG is the leading community activist science-based AIDS policy, research, and treatment advocacy think tank; TAG's activism speeds up research on HIV basic science, treatment, prevention, and vaccines; hepatitis and tuberculosis (TB) co-infection; U.S. and global treatment access; and community empowerment. TAG leads and participates in activist coalitions in the United States and around the world to expand access to effective treatment for HIV and its most common co-infections. TAG catalyzes efforts to strengthen and expand research on HIV and related diseases so that people with HIV can live long and healthy lives. TAG's ultimate goal is to accelerate research for a cure and a vaccine for HIV.